Recruiting A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD NCT05231785 Conditions Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more Locations Clinical Trial Site — La Jolla, California, United States Clinical Trial Site — Indianapolis, Indiana, United States Clinical Trial Site — Montreal, Canada Clinical Trial Site — Toronto, Canada View more locations Show fewer locations Loading locations... View Trial Details
Recruiting FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases NCT06539169 Conditions Alpha-Thalassemia, Alzheimer Disease, Amyloidosis, +104 more Locations xCures — Los Altos, California, United States View Trial Details
